7,330
Views
12
CrossRef citations to date
0
Altmetric
Commentary

Cannabis legalization: progress in harm reduction approaches for substance use and misuse

&
Pages 707-712 | Received 11 Oct 2019, Accepted 11 Oct 2019, Published online: 22 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Emily Jenkins, Tania Dearden, Ana Figueras, Liza McGuinness, Alayna Ewert & Rebecca Haines-Saah. (2023) Cannabis education resources for parents: an environmental scan and critical content analysis in the context of legalization. Drugs: Education, Prevention and Policy 30:2, pages 124-140.
Read now

Articles from other publishers (11)

Charles A. Warnock, Ashlin R. Ondrusek, E. Jennifer Edelman, Trace Kershaw & Jessica L. Muilenburg. (2024) Perspectives regarding cannabis use: Results from a qualitative study of individuals engaged in substance use treatment in Georgia and Connecticut. Drug and Alcohol Dependence Reports 11, pages 100228.
Crossref
Roula Haddad, Christian Dagenais, Christophe Huynh & Jean-Sébastien Fallu. (2024) Facilitators of and barriers to healthcare providers’ adoption of harm reduction in cannabis use: a scoping review protocol. BMJ Open 14:4, pages e078427.
Crossref
Sevar Mammadova, Aysel Guliyeva, Tatiana Kvasnikova, Anna Serebrennikova & Yuliya Tikhonova. (2023) Cannabis Legalization: Social Risk Assessment and Economic Forecast. Accounting, Economics, and Law: A Convivium 0:0.
Crossref
Iain W. H. Oswald, Twinkle R. Paryani, Manuel E. Sosa, Marcos A. Ojeda, Mark R. Altenbernd, Jonathan J. Grandy, Nathan S. Shafer, Kim Ngo, Jack R. PeatIIIIII, Bradley G. Melshenker, Ian Skelly, Kevin A. Koby, Michael F. Z. Page & Thomas J. Martin. (2023) Minor, Nonterpenoid Volatile Compounds Drive the Aroma Differences of Exotic Cannabis . ACS Omega 8:42, pages 39203-39216.
Crossref
Matteo Scopetti, Martina Padovano, Michela Peruch, Monica Concato, Tommaso Livieri, Davide Radaelli & Stefano D’Errico. (2023) Recreational Cannabis Use: Regulatory Aspects, Public Opinion and Concerns for Public Health. Current Pharmaceutical Biotechnology 24:6, pages 728-740.
Crossref
Jude Ball, Jane Zhang, James Stanley, Joseph Boden, Andrew Waa, David Hammond & Richard Edwards. (2023) Early‐onset smoking and vaping of cannabis: Prevalence, correlates and trends in New Zealand 14–15‐year‐olds. Drug and Alcohol Review 42:3, pages 592-603.
Crossref
Russell C. Callaghan, Marcos Sanches, Robin M. Murray, Sarah Konefal, Bridget Maloney-Hall & Stephen J. Kish. (2022) Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015–2019. The Canadian Journal of Psychiatry 67:8, pages 616-625.
Crossref
Iain W. H. Oswald, Marcos A. Ojeda, Ryan J. Pobanz, Kevin A. Koby, Anthony J. Buchanan, Josh Del Rosso, Mario A. Guzman & Thomas J. Martin. (2021) Identification of a New Family of Prenylated Volatile Sulfur Compounds in Cannabis Revealed by Comprehensive Two-Dimensional Gas Chromatography . ACS Omega 6:47, pages 31667-31676.
Crossref
Elizabeth A. Minton & Paige Gardiner. (2021) The missing role of moral values in anti‐vaping messaging. Journal of Consumer Affairs 55:3, pages 1040-1061.
Crossref
Camille Gourdet, François Gagnon, Craig Moscetti & Ivana Obradovic. (2021) Regulating Private and Public Places of Non-Medical Cannabis Consumption in North America: Public Health and Public Safety Issues. Journal of Canadian Studies 55:2, pages 279-306.
Crossref
Justin Matheson & Bernard Le Foll. (2020) Cannabis Legalization and Acute Harm From High Potency Cannabis Products: A Narrative Review and Recommendations for Public Health. Frontiers in Psychiatry 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.